Lipid lowering medication and hepatotoxicity
Open Access
- 15 September 2001
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 250 (3), 183-185
- https://doi.org/10.1046/j.1365-2796.2001.00887.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Use and Monitoring of "Statin" Lipid-Lowering Drugs Compared With GuidelinesArchives of Internal Medicine, 2001
- Drug-induced liver diseasesJournal of Hepatology, 2000
- The pharmacokinetics and pharmacodynamics of agents proven to raise high-density lipoprotein cholesterolThe American Journal of Cardiology, 2000
- Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue InjuryJournal of Biological Chemistry, 2000
- Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined HyperlipidemiaThe American Journal of Cardiology, 1997
- Hepatotoxicity in drug development: detection, significance and solutionsJournal of Hepatology, 1997
- Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patientsBritish Journal of Dermatology, 1996
- Methotrexate-lnduced Liver CirrhosisDermatology, 1996
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990